Lee Ainslie Acadia Pharmaceuticals Inc Transaction History
Maverick Capital LTD
- $5.17 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding ACAD
# of Institutions
316Shares Held
164MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$815 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$265 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$229 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$165 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$139 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.08B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...